CompletedNot Applicable

Multicenter Perspective Study: Clinical Evaluation of the Persona MC® With Preservation or Sacrifice of the PCL

Italy7 participantsStarted 2019-12-20

Plain-language summary

Prospective, multicenter study on the Total Knee Prosthesis available on the market "Persona Medial Congruent® knee". Primary endpoint -Evaluation of the survival of the implant after 5 years of follow-up Secondary endpoints * Evaluation of the survival of the implant at 10 years of follow up. * Evaluation of clinical and radiographic outcomes in Italian patients undergoing total knee replacement with the Persona Medial Congruent® implant with sacrifice or retention of the posterior cruciate ligament (PCL)

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis
✓. Collagen disorders and/or avascular necrosis of the femoral condyle
✓. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
✓. Moderate valgus, varus, or flexion deformities
✓. The salvage of previously failed surgical attempts that did not include partial or total knee arthroplasty of the ipsilateral knee

What they're measuring

Evaluate the safety based on implant survivorship at 5 years follow up

Timeframe: 72 months

Trial details

NCT IDNCT04244929

SponsorIstituto Ortopedico Rizzoli

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-20

View on ClinicalTrials.gov More Prosthesis Survival trials